Literature DB >> 26060383

How to Treat Obstructions in Patients with Hypertrophic Cardiomyopathy.

Josef Veselka1.   

Abstract

Hypertrophic cardiomyopathy (HCM) is characterized by the presence of increased thickness of the left ventricular wall that is not solely explained by abnormal loading conditions. Two-thirds of the patients with HCM have an obstruction in the left ventricle after provocation or even while at rest. This obstruction is associated with more symptoms and a worse prognosis. The two main therapeutic approaches for treating a left ventricular obstruction are alcohol septal ablation and surgical myectomy. Both these techniques are discussed in this article. Currently, the final decision concerning the optimal invasive therapy for patients with obstructive HCM must be individualized to each patient depending on his/her wishes and expectations, way of life, age, heart morphology, and hemodynamics, as well as the experience of the treating center.

Entities:  

Keywords:  alcohol septal ablation; hypertrophic cardiomyopathy; surgical myectomy

Year:  2015        PMID: 26060383      PMCID: PMC4452602          DOI: 10.1055/s-0034-1396900

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  29 in total

1.  Surgical relief of diffuse subvalvular aortic stenosis.

Authors:  J W KIRKLIN; F H ELLIS
Journal:  Circulation       Date:  1961-10       Impact factor: 29.690

2.  The history of alcohol septal ablation.

Authors:  Horst J Kuhn
Journal:  Cardiovasc Revasc Med       Date:  2010 Oct-Dec

3.  One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response.

Authors:  L Faber; D Welge; D Fassbender; H K Schmidt; D Horstkotte; H Seggewiss
Journal:  Clin Res Cardiol       Date:  2007-09-25       Impact factor: 5.460

4.  Controversies in cardiovascular medicine. Hypertrophic obstructive cardiomyopathy: alcohol septal ablation.

Authors:  Michael A Fifer; Ulrich Sigwart
Journal:  Eur Heart J       Date:  2011-03-29       Impact factor: 29.983

5.  Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age.

Authors:  Barry J Maron; Ethan J Rowin; Susan A Casey; Tammy S Haas; Raymond H M Chan; James E Udelson; Ross F Garberich; John R Lesser; Evan Appelbaum; Warren J Manning; Martin S Maron
Journal:  Circulation       Date:  2012-12-30       Impact factor: 29.690

6.  Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.

Authors:  Steve R Ommen; Barry J Maron; Iacopo Olivotto; Martin S Maron; Franco Cecchi; Sandro Betocchi; Bernard J Gersh; Michael J Ackerman; Robert B McCully; Joseph A Dearani; Hartzell V Schaff; Gordon K Danielson; A Jamil Tajik; Rick A Nishimura
Journal:  J Am Coll Cardiol       Date:  2005-08-02       Impact factor: 24.094

7.  Early outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a European multicenter and multinational study.

Authors:  Josef Veselka; Thorsten Lawrenz; Christoph Stellbrink; David Zemanek; Marian Branny; Jaroslav Januska; Jan Sitar; Pawel Dimitrow; Jan Krejci; Maciej Dabrowski; Stanislav Mizera; Thomas Bartel; Horst Kuhn
Journal:  Catheter Cardiovasc Interv       Date:  2013-11-07       Impact factor: 2.692

8.  Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population.

Authors:  Josef Veselka; Jan Krejčí; Pavol Tomašov; David Zemánek
Journal:  Eur Heart J       Date:  2014-01-24       Impact factor: 29.983

9.  Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy.

Authors:  Paul Sorajja; Steve R Ommen; David R Holmes; Joseph A Dearani; Charanjit S Rihal; Bernard J Gersh; Ryan J Lennon; Rick A Nishimura
Journal:  Circulation       Date:  2012-10-17       Impact factor: 29.690

Review 10.  Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a review of the literature.

Authors:  Josef Veselka
Journal:  Med Sci Monit       Date:  2007-04
View more
  1 in total

1.  Three-Dimensional Heart Printing for Planning of Septal Reduction Therapy in Patients with Hypertrophic Obstructive Cardiomyopathy.

Authors:  Josef Veselka; Theodor Adla; Radka Adlova; Thomas Bartel
Journal:  Int J Angiol       Date:  2018-04-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.